Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VHH01

Home DrugsVHH01

VHH01

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

NANOBODY TARGETING BCMA, CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
EP 4644418 A1Applicant: HEBEI SENLANG BIOTECHNOLOGY CO LTDPriority: 2022
CN
EP
WO
3 publications
抗CD123的纳米抗体、嵌合抗原受体及其应用
CN 115724972 BApplicant: 河北森朗生物科技有限公司Priority: 2022
CN
Chimeric antigen receptor targeting CD123 and CD7 and application thereof
CN 116041535 AApplicant: HEBEI SENLANG BIOTECHNOLOGY CO LTDPriority: 2022
CN